Recurrent pericarditis: moving from the middle ages to renaissance
- PMID: 36316101
- DOI: 10.1136/heartjnl-2022-321749
Recurrent pericarditis: moving from the middle ages to renaissance
Erratum in
-
Correction: Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.Heart. 2023 Dec 20;110(2):e1. doi: 10.1136/heartjnl-2022-321328corr1. Heart. 2023. PMID: 38123179 Free PMC article. No abstract available.
Keywords: Pericarditis.
Conflict of interest statement
Competing interests: GL has received consultant fees from Kiniksa Pharmaceuticals.
Comment on
-
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.Heart. 2023 Jan 27;109(4):297-304. doi: 10.1136/heartjnl-2022-321328. Heart. 2023. PMID: 36316102 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical